欢迎来到天天文库
浏览记录
ID:33400619
大小:1.74 MB
页数:28页
时间:2019-02-25
《应用lucentis治疗视网膜分支静脉阻塞引起黄斑消肿的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、分类号——学校代码!Ql堑ICS——学号垫堕盟幽薹{£~菱一3藿肉蒙古民庆大学硕士学位论文应用lucentis治疗视网膜分支静脉阻塞引起黄斑水肿的临床研究TheCliniealResearchofLucentisonMacularEdemacausedbyBranchRentinalVeinOcclusion申请人:杨玉洁学科专业:中西医结合临床研究方向:蒙西医结合眼科学学位类别:学术学位指导教师:佟艳秋教授论文提交日期:二。一二年四月摘要目的:观察Lucentis治疗视网膜分支静脉阻塞引起黄斑水肿的临床效果与安全性。方法:选择2010年4月一2011
2、年8月就诊于我院眼科的视网膜分支静脉阻塞引起黄斑水肿的患者,排除已经进行过玻璃体腔注射其它药物或行眼底激光治疗者,且年龄在80岁以下的60例患者,分别给予玻璃体腔注射Lucentis0.5mg/次,观察用药后第1天、l周、1个月、3个月视力和黄斑区水肿的变化情况,以及用药后发生的不良反应。‘结果:60例患者随访3个月后,视力、黄斑水肿均有改善。注射前及注射后第1天、l周、1个月、3个月患者的平均IogMARBCVA分别为1.00±0.19、0.77±0.18、0.58±0.20、0.39±0.17、0.41±0.20,治疗后第1天、I周、i个月、3个月
3、较治疗前视力明显改善,且差异具有统计学意义(P4、但本研究随访时间短,对于视力的稳定性、黄斑区水肿的复发情况需要进一步的大样本临床研究。关键词:兰尼单抗;视网膜分支静脉阻塞;黄斑水肿TheclinicalresearchofLucentisonmacularedemacausedbybranchretinalveinocclusionAbstractObjective:ToobservetheelinicaleffectandsaltyonmacularedemacasusedbyBIWOwithLucentis.Methods:FromApril2010toAugust2011,60patients5、withmacularedemacasusedbyBRvOadmittedtoourhospital,eliminatethepatientwithintravitreousinjectotherdrugsorfunduslaser.60patientsbelow80year-old,receivedintravitreousiIljeCtionof0.5mg(0.05mL)Lucentisrespectively,eyesight,variationofmacularareaanduntowardeffectwereobservedaftertrea6、tment1day,1week,1monthand3month.Results:After60patientswerefollowedupfor3months,theeyesightandmacularedemawerevariation.Beforetheinjectionandafterinjeetion1‘day,1week,lmonthand3monththeaverageoflogM[ARBCVAwere1.00±0.19,0.77±0.18,O.58±0.20,0.39±0、l7and0.41±0.20respectively,aftert7、reatmentlday,1week,1monthand3monthwereimprovedthanbeforetreatment(P<0.05).111enbeforetheinjectionandafterinjection1w,lmo,3motheaverageofCMTwere444.27±113.37um,368.18±83.74pm.243.02±37.211.tmaM256.10±45.97umrespectively,aftertreatment1week.1monthand3monthwereimprovedthanbeforetre8、atment(P<0.05).In60patients,nobodaywasincreased
4、但本研究随访时间短,对于视力的稳定性、黄斑区水肿的复发情况需要进一步的大样本临床研究。关键词:兰尼单抗;视网膜分支静脉阻塞;黄斑水肿TheclinicalresearchofLucentisonmacularedemacausedbybranchretinalveinocclusionAbstractObjective:ToobservetheelinicaleffectandsaltyonmacularedemacasusedbyBIWOwithLucentis.Methods:FromApril2010toAugust2011,60patients
5、withmacularedemacasusedbyBRvOadmittedtoourhospital,eliminatethepatientwithintravitreousinjectotherdrugsorfunduslaser.60patientsbelow80year-old,receivedintravitreousiIljeCtionof0.5mg(0.05mL)Lucentisrespectively,eyesight,variationofmacularareaanduntowardeffectwereobservedaftertrea
6、tment1day,1week,1monthand3month.Results:After60patientswerefollowedupfor3months,theeyesightandmacularedemawerevariation.Beforetheinjectionandafterinjeetion1‘day,1week,lmonthand3monththeaverageoflogM[ARBCVAwere1.00±0.19,0.77±0.18,O.58±0.20,0.39±0、l7and0.41±0.20respectively,aftert
7、reatmentlday,1week,1monthand3monthwereimprovedthanbeforetreatment(P<0.05).111enbeforetheinjectionandafterinjection1w,lmo,3motheaverageofCMTwere444.27±113.37um,368.18±83.74pm.243.02±37.211.tmaM256.10±45.97umrespectively,aftertreatment1week.1monthand3monthwereimprovedthanbeforetre
8、atment(P<0.05).In60patients,nobodaywasincreased
此文档下载收益归作者所有